Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J H Rex

Showing results (1-10 of 106) with videos related to

Pageof 11
Sort By:
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|March 1, 1996
Editorial response: catheters and candidemiaJ H Rex
Current Pharmaceutical Design|March 20, 2001
Lipid-based antifungal agents: current statusS Arikan, J H Rex
Current Opinion in Investigational Drugs (London, England : 2000)|September 22, 2001
Nystatin LF (Aronex/Abbott)S Arikan, J H Rex
Journal of Medical and Veterinary Mycology : Bi-Monthly Publication of the International Society for Human and Animal Mycology|January 1, 1990
Administration of potassium iodide to normal volunteers does not increase killing of Sporothrix schenckii by their neutrophils or monocytesJ H Rex, J E Bennett
New Horizons (Baltimore, Md.)|August 1, 1996
Resistance to antifungal agents in the critical care setting: problems and perspectivesM D Martins, J H Rex
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|December 10, 1999
Estimating the true cost of amphotericin BJ H Rex, T J Walsh
Critical Care Medicine|July 9, 1999
Preventing intra-abdominal candidiasis in surgical patientsJ H Rex, J D Sobel
Advances in Protein Chemistry|May 2, 2001
Glucan synthase inhibitors as antifungal agentsM B Kurtz, J H Rex
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|April 3, 2001
Prophylactic antifungal therapy in the intensive care unitJ H Rex, J D Sobel
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|June 22, 2001
Invasive candidiasis: turning risk into a practical prevention policy?J D Sobel, J H Rex
Pageof 11

Showing results (1-10 of 106) with videos related to

Sort By:
Pageof 11
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|March 1, 1996
Editorial response: catheters and candidemiaJ H Rex
Current Pharmaceutical Design|March 20, 2001
Lipid-based antifungal agents: current statusS Arikan, J H Rex
Current Opinion in Investigational Drugs (London, England : 2000)|September 22, 2001
Nystatin LF (Aronex/Abbott)S Arikan, J H Rex
Journal of Medical and Veterinary Mycology : Bi-Monthly Publication of the International Society for Human and Animal Mycology|January 1, 1990
Administration of potassium iodide to normal volunteers does not increase killing of Sporothrix schenckii by their neutrophils or monocytesJ H Rex, J E Bennett
New Horizons (Baltimore, Md.)|August 1, 1996
Resistance to antifungal agents in the critical care setting: problems and perspectivesM D Martins, J H Rex
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|December 10, 1999
Estimating the true cost of amphotericin BJ H Rex, T J Walsh
Critical Care Medicine|July 9, 1999
Preventing intra-abdominal candidiasis in surgical patientsJ H Rex, J D Sobel
Advances in Protein Chemistry|May 2, 2001
Glucan synthase inhibitors as antifungal agentsM B Kurtz, J H Rex
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|April 3, 2001
Prophylactic antifungal therapy in the intensive care unitJ H Rex, J D Sobel
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|June 22, 2001
Invasive candidiasis: turning risk into a practical prevention policy?J D Sobel, J H Rex
Pageof 11